← FDA Drug Approvals (Drugs@FDA)
RISEDRONATE SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HANGZHOU BINJIANG · Approved 2019-02-15
Drug application
- FDA Application #
ANDA207516- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RISEDRONATE SODIUM
- Generic name
- RISEDRONATE SODIUM
- Active ingredients
- RISEDRONATE SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- HANGZHOU BINJIANG
- Manufacturer
- Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd
- First approval
- 2019-02-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown